Interluekin-1 beta genetic polymorphism influences the impact of cytochrome P 2C19 genotype on the cure rate of H. pylori eradication therapy

Motowo Mizuno; Susumu Take; Kuniharu Ishiki; Hiroyuki Okada; Yasushi Shiratori

Interluekin-1 beta genetic polymorphism influences the impact of cytochrome P 2C19 genotype on the cure rate of H. pylori eradication therapy

Motowo Mizuno, Susumu Take, Kuniharu Ishiki, Hiroyuki Okada, Yasushi Shiratori

Research output: Contribution to journal › Review article › peer-review

Abstract

Genetic polymorphism of interleukin(IL)-1 beta is associated with differences in gastric acid suppression in response to H. pylori infection. Thus, the polymorphism might affect H. pylori eradication therapy since antibiotics used in treatment regimens may be acid-sensitive. We examined the impact of IL-1 beta genetic polymorphism on the cure rate of triple therapy for H. pylori in relation to cytochrome P(CYP)2C19 genotype. In the normal acid-secretion IL-1 beta genotype group, the cure rate among CYP2C19 poor metabolizers was significantly higher than among those in the CYP2C19 extensive metabolizer groups. IL-1 beta genetic polymorphism, although not an independent factor in treatment outcome, influences the impact of the CYP2C19 genotype on the cure rate of H. pylori eradication therapy.

Original language	English
Pages (from-to)	455-458
Number of pages	4
Journal	Nippon rinsho. Japanese journal of clinical medicine
Volume	62
Issue number	3
Publication status	Published - Mar 2004

ASJC Scopus subject areas

Medicine(all)

Fingerprint Dive into the research topics of 'Interluekin-1 beta genetic polymorphism influences the impact of cytochrome P 2C19 genotype on the cure rate of H. pylori eradication therapy'. Together they form a unique fingerprint.

Cite this

Interluekin-1 beta genetic polymorphism influences the impact of cytochrome P 2C19 genotype on the cure rate of H. pylori eradication therapy. / Mizuno, Motowo; Take, Susumu; Ishiki, Kuniharu; Okada, Hiroyuki; Shiratori, Yasushi.

In: Nippon rinsho. Japanese journal of clinical medicine, Vol. 62, No. 3, 03.2004, p. 455-458.

Research output: Contribution to journal › Review article › peer-review

@article{24b06ea6d3d64a25a750fdbd6c44b453,

title = "Interluekin-1 beta genetic polymorphism influences the impact of cytochrome P 2C19 genotype on the cure rate of H. pylori eradication therapy",

abstract = "Genetic polymorphism of interleukin(IL)-1 beta is associated with differences in gastric acid suppression in response to H. pylori infection. Thus, the polymorphism might affect H. pylori eradication therapy since antibiotics used in treatment regimens may be acid-sensitive. We examined the impact of IL-1 beta genetic polymorphism on the cure rate of triple therapy for H. pylori in relation to cytochrome P(CYP)2C19 genotype. In the normal acid-secretion IL-1 beta genotype group, the cure rate among CYP2C19 poor metabolizers was significantly higher than among those in the CYP2C19 extensive metabolizer groups. IL-1 beta genetic polymorphism, although not an independent factor in treatment outcome, influences the impact of the CYP2C19 genotype on the cure rate of H. pylori eradication therapy.",

author = "Motowo Mizuno and Susumu Take and Kuniharu Ishiki and Hiroyuki Okada and Yasushi Shiratori",

year = "2004",

month = mar,

language = "English",

volume = "62",

pages = "455--458",

journal = "Nippon rinsho. Japanese journal of clinical medicine",

issn = "0047-1852",

publisher = "Nipponrinsho Co., Inc.",

number = "3",

}

TY - JOUR

T1 - Interluekin-1 beta genetic polymorphism influences the impact of cytochrome P 2C19 genotype on the cure rate of H. pylori eradication therapy

AU - Mizuno, Motowo

AU - Take, Susumu

AU - Ishiki, Kuniharu

AU - Okada, Hiroyuki

AU - Shiratori, Yasushi

PY - 2004/3

Y1 - 2004/3

N2 - Genetic polymorphism of interleukin(IL)-1 beta is associated with differences in gastric acid suppression in response to H. pylori infection. Thus, the polymorphism might affect H. pylori eradication therapy since antibiotics used in treatment regimens may be acid-sensitive. We examined the impact of IL-1 beta genetic polymorphism on the cure rate of triple therapy for H. pylori in relation to cytochrome P(CYP)2C19 genotype. In the normal acid-secretion IL-1 beta genotype group, the cure rate among CYP2C19 poor metabolizers was significantly higher than among those in the CYP2C19 extensive metabolizer groups. IL-1 beta genetic polymorphism, although not an independent factor in treatment outcome, influences the impact of the CYP2C19 genotype on the cure rate of H. pylori eradication therapy.

AB - Genetic polymorphism of interleukin(IL)-1 beta is associated with differences in gastric acid suppression in response to H. pylori infection. Thus, the polymorphism might affect H. pylori eradication therapy since antibiotics used in treatment regimens may be acid-sensitive. We examined the impact of IL-1 beta genetic polymorphism on the cure rate of triple therapy for H. pylori in relation to cytochrome P(CYP)2C19 genotype. In the normal acid-secretion IL-1 beta genotype group, the cure rate among CYP2C19 poor metabolizers was significantly higher than among those in the CYP2C19 extensive metabolizer groups. IL-1 beta genetic polymorphism, although not an independent factor in treatment outcome, influences the impact of the CYP2C19 genotype on the cure rate of H. pylori eradication therapy.

UR - http://www.scopus.com/inward/record.url?scp=1842509000&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1842509000&partnerID=8YFLogxK

M3 - Review article

C2 - 15038086

AN - SCOPUS:1842509000

VL - 62

SP - 455

EP - 458

JO - Nippon rinsho. Japanese journal of clinical medicine

JF - Nippon rinsho. Japanese journal of clinical medicine

SN - 0047-1852

IS - 3

ER -